Matarin Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Matarin Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$301K	Buy	+26,071	New	+$238K	0.07%	175

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Matarin Capital Management's CDMO Position: Q4 2020 in Review

Matarin Capital Management opened a new position in Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2020: 26,071 shares worth $301K. The stake represents 0.07% of the portfolio and ranks #175 among its holdings.

147 funds tracked by Wall St. Rank hold CDMO as of Q4 2020.

Matarin Capital Management held 26,071 shares of Avid Bioservices, Inc. Common Stock worth $301K as of Q4 2020.
Avid Bioservices, Inc. Common Stock was a new Matarin Capital Management position in Q4 2020.
Avid Bioservices, Inc. Common Stock made up 0.07% of Matarin Capital Management's portfolio in Q4 2020, its #175 holding.
147 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2020.

Based on Matarin Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.